HIGHLIGHTS
- who: Lin Zhang from the Beijing Institute of Radiation Medicine, Beijing, People`s Republic of China Medical Research Center, The Affiliate Hospital of Qingdao University have published the article: Comparison of CD146u2009+/u2212u2009mesenchymal stem cells in improving premature ovarian failure, in the Journal: (JOURNAL)
- what: The CD146 +/- subsets do not show much difference in the repair of chemotherapy-induced ovarian damage.
- how: Ovary mRNA sequencing data indicated that UC-MSCs therapy improved ovarian endocrine locally which was through PPAR and cholesterol metabolism pathways. Data were analyzed with the 2 -u0394u0394Ct method. The above . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.